To this end, we treated MCF-7, a well-differentiated and non-invasive human BC cell line, with the chemical inhibitors IC87114 and Vps34-IN1, selective for p110δ and Vps34 PI3K, respectively. This evidence concerns the gene PIK3CA and breast cancer.